Expertise in
6
conditions

Osvaldo D. Messina

Investigaciones Reumatologicas Y Osteologicas Srl, B, AR 
Expertise in
6
conditions
Investigaciones Reumatologicas Y Osteologicas Srl, B, AR 

Overview

Osvaldo Messina practices practicing medicine in Investigaciones Reumatologicas Y Osteologicas Srl, Argentina.

Mr. Messina is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Osteoporosis, Fibromyalgia, Postmenopausal Osteoporosis, and Arthritis.

He is actively involved in clinical research, co-authoring 47 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Investigaciones Reumatologicas Y Osteologicas Srl, B, Argentina
Other Locations
Buenos Aires, C, Argentina
Argerich, B, Argentina

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
Enrollment Status: Terminated
Publish Date: February 07, 2024
Intervention Type: Drug, Biological
Study Drugs: Otilimab, csDMARD
Study Phase: Phase 3
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
View 1 Less Clinical Trial

47 Total Publications

Osteoimmunology: Can We Prevent Bone Loss in Rheumatoid Arthritis with Modern Antirheumatic Drugs?
Osteoimmunology: Can We Prevent Bone Loss in Rheumatoid Arthritis with Modern Antirheumatic Drugs?
Journal: Calcified tissue international
Published: December 21, 2025

Frequently Asked Questions about Osvaldo D. Messina

Is Osvaldo D. Messina a top-rated expert for Osteoporosis?

MediFind is an objective health platform that identifies experts based on real-world data. Osvaldo D. Messina is classified as an Distinguished expert for Osteoporosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Osvaldo D. Messina participate in research or clinical trials?

Yes. Osvaldo D. Messina has published 47 articles and abstracts on conditions like Osteoporosis. You can view a list of Osvaldo D. Messina's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Messina's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile